NEWRegulation

FATE Therapeutics Inc Form 144 Filed on 20 May 2023

Published on 5/20/2026

#FATE#SEC#Form144
FATE Therapeutics Inc Form 144 Filed on 20 May 2023

AI Summary

On 20 May 2023, FATE Therapeutics Inc (FATE) filed Form 144 with the SEC. This form is utilized for the sale of restricted and control securities, indicating potential stock sales by insiders or affiliates. The filing is part of regular regulatory requirements, ensuring transparency in equity transactions. Monitoring these filings can provide insight into shareholder sentiment and potential market movements.

Source: Read original article (opens in new tab)

Related News

Oklo Inc. (OKLO) Form 144 Filed on May 20, 2023
Markets

Oklo Inc. (OKLO) Form 144 Filed on May 20, 2023

May 20

Amazon (AMZN) Defeats Appeal Over Tariff Evasion Claims
Regulation

Amazon (AMZN) Defeats Appeal Over Tariff Evasion Claims

May 20

Freightos Ltd (CRGO) Form 144 Filed on May 20
Markets

Freightos Ltd (CRGO) Form 144 Filed on May 20

May 20

Morgan Stanley (MS) Requires Separate Phones for China Trips
Regulation

Morgan Stanley (MS) Requires Separate Phones for China Trips

May 20